UPDATE FOR SHAREHOLDERS REGARDING VOLUNTARY SUSPENSION OF INNOVADERMA SHARES ON EURONEXT
InnovaDerma PLC (“Innovaderma” or the “Group”)
The Board of InnovaDerma can update shareholders that it continues to progress as planned on the strategic corporate action mentioned in the announcement dated 25th, March, 2016. The intention of the board is to progress with a listing on another European Exchange and the board is already making good headway in getting a prospectus approved in preparation for listing. The board will provide further guidance on this progress very shortly.
If you have any queries relating to the above, please contact the company’s Executive Director, Joe Bayer on +61417870743.
InnovaDerma™ PLC www.innovaderma.com is an innovative and fast growing UK head quartered publicly listed public company (Euronext Paris ‘MLIDP’) specialising in research, manufacture and marketing of clinically proven, cutting edge and innovative products in hair loss, anti-ageing and beauty sectors. With presence in United Kingdom, Australia, New Zealand, Philippines, South Africa, Hong Kong and South Korea, the company is on a growth trajectory with a fast expanding global operational and retail footprint and revenue base.